Skip to content

Ferring

Active Public limited companyfounded 1985active for 41 yearsLennikse Baan 451, 1070 AnderlechtKBO/BCE: BE 0428.038.135 subsidiary of #8 oldest company in the Brussels-Capital Region, Pharmaceuticals sector

Annual accounts 2025

full format, filed on 13-10-2026, 74 days late
€20.4m
▼ 0.1%
€710,900
▲ 14.1%
-
-
28.1%
▼ 6.2 percentage points
1.46
▼ 0.17

Money flows

of every €100 of turnover, €2.25 remains as profit in 2025

Balance sheet

balance sheet total €11.0m on 31-12-2025
What the company ownsHow it is paid for

in €m

in euro

Position in the sector

28.1%

Higher than 17% of the 61 companies filing full accounts in pharmaceuticals (NACE 21) in 2025.

1.46

Higher than 43% of the 60 companies filing full accounts in pharmaceuticals (NACE 21) in 2025.

4.2%

Higher than 46% of the 61 companies filing full accounts in pharmaceuticals (NACE 21) in 2025.

Ferring Middle half of the sector 80% of the sector Full accounts in pharmaceuticals (NACE 21)

Net result: middle half · Equity: middle half · Balance sheet total: middle half · Working capital: middle half · Staff: bottom quarter

Staff

Men and women78% women

3 men and 10.8 women in full-time equivalents in 2025.

€199,904

Per full-time equivalent, a man cost €209,587 and a woman €197,214.

-4 employees

employees who joined employees who left

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015201420132012201120102009200820072006
-623,116941,775687,675997,091623,537968,7011.1m1.1m737,502831,139871,9931.1m858,459754,826608,1951.0m910,764-865,634-
-407,922651,789536,708852,930220,498651,333765,013652,583454,470526,666568,292696,490545,471479,884392,767741,598900,218-775,040-
--357-10-505,7344,07810,88828,05566,52517,4561,84913,95357,295405,15131,3568,1399,7766,941-
-623-751-78,3667,918-6,383153,180-178,180179,223-789291-1.6m-1.9m3.5m-1.1m184,074-218,152-1.5m1.6m-8.7m-
3.4m2.9m4.0m4.6m4.4m4.2m3.2m2.5m1.8m1.2m4.3m3.8m3.2m2.5m2.0m2.8m3.4m4.9m3.8m4.6m
3.5%3.1%4.4%3.1%4.3%2.6%3.7%4.5%4.2%2.9%3.4%3.6%4.6%3.7%3.4%2.9%5.1%4.6%-5.0%-
28.1%34.3%41.6%41.5%39.7%41.4%32.9%34.3%24.2%16.8%52.0%45.9%32.5%43.7%27.8%35.1%49.1%48.7%50.1%29.0%
1.461.621.811.711.772.181.541.571.341.212.051.801.441.691.331.561.992.062.031.42
1.460.750.811.011.071.010.931.020.830.711.441.261.141.301.001.211.551.571.541.22
2.531.921.401.411.421.111.971.833.014.750.921.182.081.282.591.841.041.051.002.45
14.8%15.5%17.4%11.7%21.0%5.3%19.2%28.5%33.6%33.9%10.4%12.6%17.9%16.6%18.6%13.9%21.7%19.2%-21.0%-
4.2%5.3%7.3%4.8%8.3%2.2%6.3%9.8%8.1%5.7%5.4%5.8%5.8%7.2%5.2%4.9%10.7%9.3%-10.5%-
-12.7137.1268.99over 100over 100over 100over 100over 100over 100over 100over 100over 100over 100-over 100----
172 days60 days63 days79 days62 days53 days58 days60 days63 days56 days62 days60 days70 days71 days74 days74 days63 days70 days74 days50 days
46 days43 days62 days100 days88 days49 days92 days59 days53 days81 days56 days74 days137 days63 days121 days101 days68 days98 days65 days76 days

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015201420132012201120102009200820072006
Balance sheet: assets
20/58 11.0m7.7m8.9m11.0m10.2m7.7m9.2m7.1m7.2m6.9m8.6m8.7m10.8m6.6m8.6m7.8m6.9m9.5m7.5m15.6m
21/28 11,63311,63311,99014,40917,12721,23772,518140,838197,087233,189227,609272,898335,163390,885405,13032,94813,32614,85116,745-
21 --000000004,88219,65034,53649,66464,792-----
22/27 7,9567,9567,95510,37413,09217,15268,433135,364194,589232,781222,319252,840300,219340,813338,73331,50211,88113,40515,29919,000
23 --000002,3406,71711,62716,5361,6502,19504101,0071,6580106-
24 --02,4185,1378,96726,68843,69450,95647,03060,87876,61293,772110,644109,06530,49510,22213,40515,19319,000
26 7,9567,9567,9557,9557,9558,18541,74589,330136,916174,125144,905174,578204,251230,169229,257-----
28 3,6773,6774,0354,0354,0354,0854,0855,4752,4984084084084084081,6061,4461,4461,4461,4462,000
284/8 3,6773,6774,0354,0354,0354,0854,0855,4752,4984084084084084081,6061,4461,4461,4461,4462,000
285/8 3,6773,6774,0354,0354,0354,0854,0855,4752,4984084084084084081,6061,4461,4461,4461,4462,000
29/58 11.0m7.7m8.9m11.0m10.2m7.7m9.1m7.0m7.0m6.7m8.4m8.5m10.4m6.2m8.2m7.8m6.9m9.5m7.5m15.6m
3 04.1m4.9m4.5m4.0m4.1m3.6m2.5m2.7m2.8m2.5m2.5m2.2m1.4m2.0m1.8m1.5m2.3m1.8m2.1m
30/36 04.1m4.9m4.5m4.0m4.1m3.6m2.5m2.7m2.8m2.5m2.5m2.2m1.4m2.0m1.8m1.5m2.3m1.8m2.1m
34 04.1m4.9m4.5m4.0m4.1m3.6m2.5m2.7m2.8m2.5m2.5m2.2m1.4m2.0m1.8m1.5m2.3m1.8m2.1m
40/41 10.6m3.4m3.9m6.3m5.9m3.4m5.4m4.2m4.2m3.8m5.4m3.8m4.3m4.2m4.5m4.7m3.7m4.2m4.3m3.5m
40 9.6m3.3m3.7m4.8m3.9m3.2m3.9m4.0m4.1m3.5m3.9m3.7m4.2m4.2m4.4m4.1m3.5m3.7m3.5m3.4m
41 1.0m117,145202,7371.5m2.0m210,1301.5m187,988112,325209,5891.5m82,66983,66247,409190,493551,157214,478452,964736,295188,000
54/58 76,74577,36878,119156,485148,567154,9501,769179,9507271,5161,2251.6m3.5m9901.1m867,3531.1m2.5m958,5799.7m
490/1 265,79135,00020,000-79,3113,26984,746148,881114,513108,974487,628528,638511,348484,972570,120519,658525,957496,709450,777279,000
Balance sheet: equity and liabilities
10/49 11.0m7.7m8.9m11.0m10.2m7.7m9.2m7.1m7.2m6.9m8.6m8.7m10.8m6.6m8.6m7.8m6.9m9.5m7.5m15.6m
10/15 3.1m2.6m3.7m4.6m4.0m3.2m3.0m2.4m1.7m1.2m4.5m4.0m3.5m2.9m2.4m2.7m3.4m4.6m3.7m4.5m
10/11 322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500-
10 322,500322,500322,500322,500322,500--------------323,000
100 322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500322,500323,000
13 32,25032,25032,25032,25032,25032,25032,25032,25032,25032,2503.0m3.0m2.0m2.0m53,06453,06453,06453,06453,06353,000
130/1 32,25032,25032,25032,25032,25032,250--------------
130 32,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,25032,000
133 ----------3.0m3.0m2.0m2.0m20,81420,81420,81420,81420,81321,000
14 2.7m2.3m3.4m4.2m3.7m2.8m2.7m2.1m1.4m804,3881.1m646,9411.1m515,9482.0m2.4m3.0m4.3m3.4m-
16 72,405---383,726971,451220,788219,556207,419227,481---12,0806,62025,200----
160/5 72,405---383,726971,451220,788219,556207,419227,481---12,0806,62025,200----
164/5 72,405---383,726971,451220,788219,556207,419227,481---12,0806,62025,200----
17/49 7.8m5.0m5.2m6.4m5.8m3.5m6.0m4.5m5.3m5.5m4.1m4.7m7.3m3.7m6.2m5.1m3.5m4.9m3.7m11.1m
42/48 7.5m4.7m4.9m6.4m5.7m3.5m5.9m4.4m5.2m5.5m4.1m4.7m7.3m3.6m6.2m5.0m3.4m4.6m3.7m11.0m
43 4.0m2.0m1.3m--145,012--1.1m112,243---98,446------
430/8 4.0m2.0m1.3m-----1.1m-----------
439 -----145,012---112,243---98,446------
44 2.6m1.9m2.9m5.0m4.6m2.3m4.9m3.0m2.7m4.1m2.8m3.5m6.3m2.9m5.5m4.4m2.9m4.1m3.3m5.1m
440/4 2.6m1.9m2.9m5.0m4.6m2.3m4.9m3.0m2.7m4.1m2.8m3.5m6.3m2.9m5.5m4.4m2.9m4.1m3.3m5.1m
45 911,580762,831744,0001.4m1.2m1.1m1.0m1.4m1.4m1.3m1.3m1.1m988,723679,847650,272609,829535,534502,018347,6441.4m
450/3 148,78986,779114,177198,178248,910198,789134,505593,114565,386480,196305,347151,164300,711107,00084,664--70,097-1.1m
454/9 762,791676,052629,8231.2m935,200886,958891,561824,506848,908822,058950,750997,734688,012572,847565,608609,829535,534431,921347,644333,000
47/48 -------------------4.5m
492/3 297,317323,241289,38825,00019,50018,00024,00024,00024,00024,00049,00033,60015,91031,60050,00060,20052,813274,60551,77071,000
Income statement
70/76A 25.7m20.7m21.6m23.1m23.8m22.8m24.8m24.6m24.4m23.7m23.4m22.8m22.0m21.7m21.6m20.4m20.4m19.6m21.7m-
70 20.4m20.4m21.4m22.2m22.9m22.2m24.6m24.2m23.8m23.2m22.9m22.5m21.9m21.5m21.5m20.3m20.4m19.6m17.5m24.5m
74 5.3m310,730174,758905,095928,932--------------6.0m
76A -----2,53774443876667625,0172111641321-2,9272,916-
60/66A 25.0m20.1m20.7m22.4m22.8m22.2m23.9m23.5m23.4m23.0m22.7m22.0m21.0m20.9m20.9m19.8m19.4m18.7m22.6m-
60 17.0m13.6m14.7m15.6m16.2m14.5m16.0m14.6m14.4m14.4m14.3m14.0m13.0m12.8m12.4m11.7m11.7m11.2m15.4m21.1m
600/8 13.9m12.8m15.1m16.1m16.1m15.1m17.2m14.5m14.3m14.7m14.3m14.4m13.7m12.1m12.7m12.0m10.9m11.7m15.1m21.1m
609 3.1m726,569-456,097-515,129146,926-632,141-1.3m89,01291,686-268,56114,906-347,408-742,157608,562-288,184-255,979801,300-452,720246,594-
61 3.9m3.0m2.6m2.6m2.6m2.4m3.4m4.0m4.1m4.0m3.9m3.5m3.7m4.0m4.3m4.1m3.9m4.0m3.5m3.4m
62 2.8m2.5m2.4m3.7m3.7m3.4m3.3m3.3m3.3m3.1m3.1m3.3m3.0m3.1m2.9m2.8m2.5m2.4m2.1m1.8m
630 -02,4182,7184,06051,35271,00970,11366,24760,94462,74564,11469,67570,34233,12911,7349,66311,67010,87316,000
631/4 57,220-130,30036,784-30,019-39,836147,252-133,065133,06530,589-----1,5231,523-12,095-30,491-19,51476,119-
635/8 --0-383,726-587,725750,6631,232------12,0805,460-18,58025,200----
640/8 1.2m1.1m970,587931,333946,223970,4171.0m1.5m1.5m1.5m1.3m1.1m1.3m1.0m1.3m1.1m1.3m1.1m1.5m2.9m
66A ------322,321-----------125-
9901 710,900623,116939,357684,957993,032572,185897,6921.1m1.0m676,558768,394807,8791.0m788,117721,697596,4601.0m899,094-876,507-
75/76B 01,00768301,1053142193,7341357352314485562,628615,45884,28290,961-
75 01,00768301,1053142193,29658752314485562,628615,45884,28290,961175,000
751 01,007683-------329--161,371613,68978,49790,960175,000
752/9 00001,1053142193,29658719414485401,258-1,7695,7851-
76B -------4387666----------
65/66B 73,53353,20149,7199,96711,70513,41313,31723,43227,58133,05733,85528,86231,06919,99413,9833,0172,5882,3323,156-
65 73,53353,20149,7199,96711,70513,41313,31723,43227,58133,05733,85528,86231,06919,99413,9833,0172,5882,3323,156-
650 63,24149,01825,370-1242,2837376,8228,3891,9363,7211,1027,3232,882-3,017----
651 --0-4,676----------------
652/9 10,2924,18324,34914,64311,58111,12912,58116,61019,19231,12130,13427,76123,74617,11213,983-2,5882,3323,1563,000
9903 637,367570,922890,321674,990982,431559,086884,5931.1m973,867643,574735,824784,178971,399768,295710,756593,5251.0m983,971-785,911-
67/77 179,856163,000240,950141,000133,561389,940304,269364,504387,531250,048271,904280,000344,584293,165264,000212,493306,62795,4232-
670/3 179,856163,000245,000141,000133,561390,000306,600364,504387,531250,048271,904280,000348,000293,165264,000212,493306,62795,4232-
77 -04,050--602,331-----3,416------3,000
9904 457,511407,922649,371533,990848,870169,146580,324694,900586,336393,526463,921504,178626,815475,130446,756381,033731,935888,548-785,913-
9905 457,511407,922649,371533,990848,870169,146580,324694,900586,336393,526463,921504,178626,815475,130446,756381,033731,935888,548-785,913-
Appropriation of the result
9906 2.7m3.8m4.9m4.2m3.7m2.8m2.7m2.1m1.4m1.5m1.1m1.6m1.1m2.5m2.8m3.4m5.0m4.3m3.4m-
14P 2.3m3.4m4.2m3.7m2.8m---------------
791/2 ---------3.0m----------
792 ---------3.0m----------
691/2 -----------1.0m-2.0m------
6921 -----------1.0m-2.0m------
694/7 01.5m1.5m------3.7m----800,0001.0m2.0m---
694 01.5m1.5m------3.7m----800,0001.0m2.0m--4.5m
Social balance sheet
9087 13.815.715.318.320.724.326.226.626.624.622.923.322.424.224.42421.821.722.218.2
Men (FTE)1003 3-4.25.86.37.58.28.17.87.87.68.37.47.9------
Women (FTE)1003 10.8-11.112.514.416.81818.518.816.815.3151516.3------
Agency workers1501 ---0.510.60.80.30.20.50.50.30.10.10.50.50.30.31.6-
Hours worked1013 22,069-24,71029,56733,28833,25240,40641,16941,92139,37137,07036,34636,81938,72039,93938,79234,83735,15434,273-
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The accounts for 20 older financial years, from 1986 to 2005, were filed as documents without figures as data, scans for example.

The full notes are in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 13-10-2026.

Filings

each dot is a set of accounts, on the day it reached the National Bank

The accounts were filed on 13-10-2026. The deadline was 31-07-2026, 7 months after the close on 31-12-2025 (article 3:10 of the Companies and Associations Code). Source: NBB, 2026-00564762.

Financial year Type Filed Reference Document
31-12-2025 full format 13-10-2026 2026-00564762 PDF
31-12-2024 full format 14-07-2025 2025-00276180 PDF
31-12-2023 full format 29-07-2024 2024-00305672 PDF
31-12-2022 full format 26-07-2023 2023-00299549 PDF
31-12-2021 full format 29-06-2022 2022-20106069 PDF
31-12-2020 full format 18-06-2021 2021-22300227 PDF
31-12-2019 full format 28-04-2020 2020-10900391 PDF
31-12-2018 full format 22-03-2019 2019-07800522 PDF
31-12-2017 full format 23-03-2018 2018-07700066 PDF
31-12-2016 full format 04-04-2017 2017-08700589 PDF
31-12-2015 full format 08-04-2016 2016-09800397 PDF
31-12-2014 full format 06-05-2015 2015-11500541 PDF
31-12-2013 full format 12-05-2014 2014-12100398 PDF
31-12-2012 full format 22-04-2013 2013-09600384 PDF
31-12-2011 full format 04-05-2012 2012-11000549 PDF
31-12-2010 full format 28-03-2011 2011-06900385 PDF
31-12-2009 full format 13-04-2010 2010-09200461 PDF
31-12-2008 full format 23-06-2009 2009-28300066 PDF
31-12-2007 full format 13-05-2008 2008-14200068 PDF
31-12-2006 full format 22-03-2007 2007-08601617 PDF
31-12-2005 full format 18-04-2006 2006-11300769 PDF
31-12-2004 full format 30-03-2005 2005-09701897 PDF
31-12-2003 full format 16-04-2004 2004-11303870 PDF
31-12-2002 full format 04-07-2003 2003-39700920 PDF
31-12-2001 full format 25-07-2002 2002-42003714 PDF
31-12-2000 full format 29-06-2001 2001-30305307 PDF
31-12-1999 full format 31-07-2000 2000-48304035 PDF
31-12-1998 full format 22-09-1999 1999-48302641 PDF
31-12-1997 full format 26-11-1998 1998-58901717 PDF
31-12-1996 full format 27-08-1997 1997-39404153 PDF
31-12-1995 abbreviated format 26-03-1996 1996-04603839 PDF
31-12-1994 abbreviated format 06-04-1995 1995-05205027 PDF
31-12-1993 abbreviated format 18-05-1994 1994-08800278 PDF
31-12-1992 abbreviated format 16-06-1993 1993-13804594 PDF
31-12-1991 abbreviated format 23-06-1992 1992-13901836 PDF
31-12-1990 abbreviated format 24-10-1991 1991-29100862 PDF
31-12-1989 abbreviated format 22-05-1990 1990-05204798 PDF
31-12-1988 abbreviated format 14-07-1989 1989-16903682 PDF
31-12-1987 abbreviated format 16-06-1988 1988-08403376 PDF
31-12-1986 abbreviated format 08-05-1987 1987-05702256 PDF

Social balance sheet

Item31-12-202531-12-202331-12-202231-12-2021
Employees at the balance-sheet date13171721
full-time8121215
part-time5556
in full-time equivalents12.116.216.119.8
13.815.318.320.7
On a permanent contract13161721
Joined0103
Left4146
Agency workers, average number--0.51
Training hours---82

Source: social balance sheet in the 2021 to 2025 annual accounts

Auditor

fees
Item20252024202320222021
Fee for the audit€40,210€29,544€28,600€27,240€27,500
Other work by the auditor----€1,754
Work by parties linked to the auditor--€1,612€1,750-

Source: notes to the 2021 to 2025 annual accounts (relations with the auditor)

Public contracts

19 awards · 2023 to 2026
Raamovereenkomst aankoop van IVF geneesmiddelen: HMG gecombineerde gonadotrofines 1:1 FSH:LH activiteit
buyer: Regionaal ziekenhuis H. Hart Leuven vzwMedical equipment and pharmaceuticalsawarded 30-09-2026€567,1141 tenderTED 679890-2026
Raamovereenkomst aankoop van IVF geneesmiddelen: Kortwerkende GnRH-agonisten
buyer: Regionaal ziekenhuis H. Hart Leuven vzwMedical equipment and pharmaceuticalsawarded 30-09-2026€25,1941 tenderTED 679890-2026
Raamovereenkomst aankoop van IVF geneesmiddelen: Laaggedoseerd combinatiepreparaat FSH:LH activiteit voor non-IVF
buyer: Regionaal ziekenhuis H. Hart Leuven vzwMedical equipment and pharmaceuticalsawarded 30-09-2026€3,5501 tenderTED 679890-2026
Raamovereenkomst aankoop van IVF geneesmiddelen: Recombinant FSH bij risico op overstimulatie
buyer: Regionaal ziekenhuis H. Hart Leuven vzwMedical equipment and pharmaceuticalsawarded 30-09-2026€11,2901 tenderTED 679890-2026
Médicaments pour la procréation médicalement assistée: PHARM-2026-840 - 2
buyer: Cliniques universitaires Saint LucMedical equipment and pharmaceuticalsawarded 16-09-2026€26,5461 tenderTED 695273-2026
Show 14 more contracts
Médicaments pour la procréation médicalement assistée: PHARM-2026-840 - 4
buyer: Cliniques universitaires Saint LucMedical equipment and pharmaceuticalsawarded 16-09-2026€25,8051 tenderTED 695273-2026
Médicaments pour la procréation médicalement assistée: PHARM-2026-840 - 5
buyer: Cliniques universitaires Saint LucMedical equipment and pharmaceuticalsawarded 16-09-2026€728,8511 tenderTED 695273-2026
ATOSIBAN IV: MH-DM-012025-ATOSIBAN IV - 1
buyer: MercurHosp ASBLMedical equipment and pharmaceuticalsawarded 02-06-2025€391,3362 tendersTED 639100-2025
Raamovereenkomst voor levering van IVF medicatie: APO-2024-06 IVF Medicatie - 2
buyer: Algemeen Ziekenhuis Jan Palfijn Gent AVMedical equipment and pharmaceuticalsawarded 30-12-2024€589,8601 tenderTED 7821-2025
Raamovereenkomst voor levering van IVF medicatie: APO-2024-06 IVF Medicatie - 5
buyer: Algemeen Ziekenhuis Jan Palfijn Gent AVMedical equipment and pharmaceuticalsawarded 30-12-2024€32,8501 tenderTED 7821-2025
Raamovereenkomst voor levering van IVF medicatie: APO-2024-06 IVF Medicatie - 7
buyer: Algemeen Ziekenhuis Jan Palfijn Gent AVMedical equipment and pharmaceuticalsawarded 30-12-2024€32,8501 tenderTED 7821-2025
Raamovereenkomst voor de levering van Atosiban
buyer: Onze Lieve Vrouw Van Troost v.z.w.Medical equipment and pharmaceuticalsawarded 21-05-2024€59,2621 tenderTED 305775-2024
IVF geneesmiddelen: Humaan menopauzale gonadotrofines met een 1:1 FSH:LH activiteit
buyer: AZ Delta vzwMedical equipment and pharmaceuticalsawarded 12-04-2024€202,6021 tenderTED 226886-2024
IVF geneesmiddelen: Follitropine-Delta - Biosynthetisch FSH
buyer: AZ Delta vzwMedical equipment and pharmaceuticalsawarded 12-04-2024€8,8701 tenderTED 226886-2024
IVF geneesmiddelen: Kortwerkende injecteerbare GnRH-agonisten
buyer: AZ Delta vzwMedical equipment and pharmaceuticalsawarded 12-04-2024€15,7221 tenderTED 226886-2024
Médicaments utilisés dans le cadre de la PMA : gonadotrophines, agoniste et antagoniste de la gonadoréline: Agoniste de la gonadoréline
buyer: CHIRECMedical equipment and pharmaceuticalsawarded 02-04-2024€35,6401 tenderTED 221982-2024
Médicaments utilisés dans le cadre de la PMA : gonadotrophines, agoniste et antagoniste de la gonadoréline: Gonadotrophine urinaire humaine à activité FSH:LH 1:1
buyer: CHIRECMedical equipment and pharmaceuticalsawarded 02-04-2024€816,7341 tenderTED 221982-2024
Médicaments utilisés dans le cadre de la PMA : gonadotrophines, agoniste et antagoniste de la gonadoréline: Gonadotrophine recombinante humaine produite sur cellules humaines à activité FSH
buyer: CHIRECMedical equipment and pharmaceuticalsawarded 02-04-2024€58,2401 tenderTED 221982-2024
Carbétocine solution injectable: MH-DM-032023-CARBETOCINE - 1
buyer: MercurHosp ASBLMedical equipment and pharmaceuticalsawarded 12-12-2023€365,9042 tendersTED 772483-2023

Source: TED (Tenders Electronic Daily), Publications Office of the European Union. The values are as the buyer published them. For a framework agreement, the value is a ceiling.

Insights on Ferring

The operating result for 2025 is 14% higher than in 2024. It is a recovery after the fall in 2024.

Debt's share of the balance-sheet total rises from 65.7% to 71.2%. Equity and debt are higher.

Next steps